Nifty

:

24461.15

Sensex

:

80796.84

114.45 (0.47%)
294.85 (0.37%)

Login

Nifty
Sensex

:
:

24461.15
80796.84

114.45 (0.47%)
294.85 (0.37%)

Gufic Biosciences Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 509079 | NSE: GUFICBIO

Watchlist

NSE BSE

425.20

06-Feb-2025

Open
High
Low
Previous Close

430.30
434.85
421.00
428.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

22062
94.57
504.25
278.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,630.55
44.29
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,894.75
0.03%
6.12

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

18.20
16.32
1.16

EBITDA CAGR (%)

10 Years
5 Years
3 Years

26.17
22.86
-0.29

PAT CAGR (%)

10 Years
5 Years
3 Years

35.40
30.58
-3.49

P:E (Median)

8 Years
5 Years
3 Years

44.94
44.94
44.94

P:BV (Average)

8 Years
5 Years
3 Years

4.39
4.39
4.39

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.30
18.30
18.30

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 8.59
P/E Ratio 48.81
Revenue 807
EBITDA 146
Net Income 86
ROA 8.8
P/B Ratio 7.9
ROE 19.57
FCFF -127.24
FCFF Yield -2.87

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 207.79 201.78 2.98% 204.18 214.87 -4.98% 202.81 195.02 3.99% 194.99 173.04 12.68%
Expenses 173.85 165.32 5.16% 165.56 175.50 -5.66% 167.03 159.54 4.69% 160.77 140.89 14.11%
EBITDA 33.94 36.45 -6.89% 38.62 39.37 -1.91% 35.78 35.48 0.85% 34.23 32.15 6.47%
EBIDTM 16.33% 18.07% 18.92% 18.32% 17.64% 18.19% 17.55% 18.58%
Other Income 1.86 0.42 342.86% 0.11 0.33 -66.67% 1.26 0.88 43.18% 0.88 0.62 41.94%
Interest 4.91 3.18 54.40% 5.18 4.46 16.14% 4.62 4.07 13.51% 3.65 2.92 25.00%
Depreciation 4.62 4.14 11.59% 4.30 4.30 0.00% 4.30 4.24 1.42% 4.34 5.92 -26.69%
PBT 26.28 29.56 -11.10% 29.26 30.95 -5.46% 28.11 28.05 0.21% 27.12 23.93 13.33%
Tax 6.96 7.30 -4.66% 7.48 7.74 -3.36% 7.25 7.43 -2.42% 7.07 5.83 21.27%
PAT 19.32 22.26 -13.21% 21.78 23.21 -6.16% 20.86 20.62 1.16% 20.05 18.11 10.71%
PATM 9.30% 11.03% 10.67% 10.80% 10.28% 10.58% 10.28% 10.46%
EPS 1.93 2.22 -13.06% 2.17 2.31 -6.06% 2.08 2.06 0.97% 2.00 1.81 10.50%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 207.79 201.78 2.98% 204.18 214.87 -4.98% 202.81 0.00 0 194.99 0.00 0
Expenses 173.87 165.32 5.17% 165.56 175.50 -5.66% 167.03 0.00 0 160.77 0.00 0
EBITDA 33.92 36.45 -6.94% 38.62 39.37 -1.91% 35.78 0.00 0 34.23 0.00 0
EBIDTM 16.33% 18.07% 18.91% 18.32% 17.64% 0.00% 17.55% 0.00%
Other Income 1.86 0.42 342.86% 0.11 0.33 -66.67% 1.26 0.00 0 0.88 0.00 0
Interest 4.91 3.18 54.40% 5.18 4.46 16.14% 4.62 0.00 0 3.65 0.00 0
Depreciation 4.62 4.14 11.59% 4.30 4.30 0.00% 4.30 0.00 0 4.34 0.00 0
PBT 26.26 29.56 -11.16% 29.25 30.95 -5.49% 28.11 0.00 0 27.12 0.00 0
Tax 6.96 7.30 -4.66% 7.48 7.74 -3.36% 7.25 0.00 0 7.07 0.00 0
PAT 19.31 22.26 -13.25% 21.77 23.21 -6.20% 20.86 0.00 0 20.05 0.00 0
PATM 9.29% 11.03% 10.66% 10.80% 10.28% 0.00% 10.28% 0.00%
EPS 1.93 2.22 -13.06% 2.17 2.39 -9.21% 2.08 0.00 0 2.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 809.77 806.67 690.62 779.16 487.70 378.84 350.77 305.58 245.52 202.20 151.55 Net Sales Growth 3.19% 16.80% -11.36% 59.76% 28.74% 8.00% 14.79% 24.46% 21.42% 33.42% Cost Of Goods Sold 373.64 339.06 295.46 368.49 226.12 156.47 161.37 128.58 107.42 90.84 73.47 Gross Profit 436.13 467.60 395.16 410.67 261.58 222.37 189.40 177.01 138.10 111.35 78.08 GP Margin 53.86% 57.97% 57.22% 52.71% 53.64% 58.70% 54.00% 57.93% 56.25% 55.07% 51.52% Total Expenditure 667.21 660.79 555.97 631.13 403.78 326.72 304.78 266.80 222.57 182.51 137.28 Power & Fuel Cost - 17.79 15.24 11.00 9.94 8.23 3.43 3.58 3.51 3.57 3.16 % Of Sales - 2.21% 2.21% 1.41% 2.04% 2.17% 0.98% 1.17% 1.43% 1.77% 2.09% Employee Cost - 109.63 86.73 85.61 66.22 58.59 46.85 44.62 41.03 31.95 19.23 % Of Sales - 13.59% 12.56% 10.99% 13.58% 15.47% 13.36% 14.60% 16.71% 15.80% 12.69% Manufacturing Exp. - 89.75 72.21 82.20 46.74 43.26 43.16 37.69 28.94 23.54 15.48 % Of Sales - 11.13% 10.46% 10.55% 9.58% 11.42% 12.30% 12.33% 11.79% 11.64% 10.21% General & Admin Exp. - 53.61 44.70 37.97 23.69 32.47 32.32 31.50 27.03 20.56 13.56 % Of Sales - 6.65% 6.47% 4.87% 4.86% 8.57% 9.21% 10.31% 11.01% 10.17% 8.95% Selling & Distn. Exp. - 40.20 31.74 28.38 17.87 17.35 11.36 13.26 9.11 8.19 8.78 % Of Sales - 4.98% 4.60% 3.64% 3.66% 4.58% 3.24% 4.34% 3.71% 4.05% 5.79% Miscellaneous Exp. - 10.75 9.88 17.48 13.20 10.36 6.29 7.57 5.53 3.85 8.78 % Of Sales - 1.33% 1.43% 2.24% 2.71% 2.73% 1.79% 2.48% 2.25% 1.90% 2.38% EBITDA 142.57 145.88 134.65 148.03 83.92 52.12 45.99 38.78 22.95 19.69 14.27 EBITDA Margin 17.61% 18.08% 19.50% 19.00% 17.21% 13.76% 13.11% 12.69% 9.35% 9.74% 9.42% Other Income 4.11 2.18 2.57 3.10 3.73 5.79 4.17 2.86 1.44 0.66 0.57 Interest 18.36 15.36 8.22 5.37 13.63 13.91 10.16 8.88 6.34 6.20 4.46 Depreciation 17.56 17.02 22.28 18.93 16.31 13.86 4.65 4.40 3.68 3.79 3.85 PBT 110.77 115.67 106.72 126.84 57.71 30.13 35.35 28.37 14.37 10.36 6.53 Tax 28.76 29.54 27.02 31.00 13.48 7.44 13.41 13.48 5.35 3.03 2.37 Tax Rate 25.96% 25.54% 25.32% 24.44% 23.36% 24.69% 37.93% 44.99% 37.23% 29.25% 36.29% PAT 82.01 86.14 79.70 95.84 44.23 22.69 21.94 16.48 9.02 7.32 4.16 PAT before Minority Interest 82.01 86.14 79.70 95.84 44.23 22.69 21.94 16.48 9.02 7.32 4.16 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 10.13% 10.68% 11.54% 12.30% 9.07% 5.99% 6.25% 5.39% 3.67% 3.62% 2.74% PAT Growth -2.60% 8.08% -16.84% 116.69% 94.93% 3.42% 33.13% 82.71% 23.22% 75.96% EPS 8.18 8.59 7.95 9.56 4.41 2.26 2.19 1.64 0.90 0.73 0.41

Description TTM Mar 24
Net Sales - 806.67 Net Sales Growth - Cost Of Goods Sold - 339.06 Gross Profit - 467.60 GP Margin - 57.97% Total Expenditure - 660.79 Power & Fuel Cost - 17.79 % Of Sales - 2.21% Employee Cost - 109.63 % Of Sales - 13.59% Manufacturing Exp. - 89.75 % Of Sales - 11.13% General & Admin Exp. - 53.61 % Of Sales - 6.65% Selling & Distn. Exp. - 40.20 % Of Sales - 4.98% Miscellaneous Exp. - 10.75 % Of Sales - 1.33% EBITDA - 145.88 EBITDA Margin - 18.08% Other Income - 2.18 Interest - 15.36 Depreciation - 17.02 PBT - 115.67 Tax - 29.54 Tax Rate - 25.54% PAT - 86.14 PAT before Minority Interest - 86.14 Minority Interest - 0.00 PAT Margin - 10.68% PAT Growth - EPS - 8.59

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 532.56 347.81 269.12 173.44 129.32 75.35 54.14 37.33 33.96 27.10 Share Capital 10.03 9.69 9.69 9.69 9.69 7.78 7.78 7.74 7.74 7.74 Total Reserves 522.53 338.11 259.42 163.74 119.63 67.56 46.35 29.59 26.22 19.36 Non-Current Liabilities 187.93 224.18 65.88 54.96 37.79 17.16 12.54 9.16 14.56 16.58 Secured Loans 153.96 190.68 47.98 35.43 19.52 11.25 4.43 3.20 4.84 8.62 Unsecured Loans 0.00 0.00 0.00 0.00 0.03 0.06 3.89 3.42 2.82 2.88 Long Term Provisions 15.38 13.29 12.39 10.23 7.93 1.86 2.26 2.29 1.39 1.41 Current Liabilities 372.05 288.21 186.40 163.66 325.60 217.72 168.55 128.18 103.68 83.61 Trade Payables 166.27 130.26 140.95 111.21 117.07 77.81 75.98 43.74 52.62 49.53 Other Current Liabilities 56.48 38.82 33.30 29.98 22.99 16.28 17.24 20.75 14.10 13.01 Short Term Borrowings 142.02 111.76 6.60 16.32 93.10 84.69 69.17 46.97 32.28 17.90 Short Term Provisions 7.28 7.37 5.55 6.15 92.44 38.95 6.16 16.73 4.67 3.16 Total Liabilities 1,092.54 860.20 521.40 392.06 492.71 310.23 235.23 174.67 152.20 127.29 Net Block 158.89 159.57 115.17 99.97 82.58 24.45 22.85 21.96 22.15 25.11 Gross Block 246.23 246.28 179.65 148.64 114.98 37.19 31.00 25.65 51.31 50.81 Accumulated Depreciation 87.34 86.71 64.48 48.67 32.40 12.74 8.15 3.68 29.17 25.71 Non Current Assets 492.07 396.08 200.65 131.48 133.58 46.34 37.02 31.42 32.69 35.81 Capital Work in Progress 307.06 169.59 40.87 13.40 30.61 9.63 2.05 0.04 0.00 0.00 Non Current Investment 1.79 0.78 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 23.12 64.35 43.65 17.12 18.54 10.16 8.73 7.60 9.01 9.17 Other Non Current Assets 1.21 1.80 0.95 0.98 1.84 2.09 3.38 1.82 1.52 1.52 Current Assets 600.47 464.11 320.75 260.58 359.13 263.89 198.20 143.25 119.51 91.48 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 200.48 183.46 115.57 94.40 122.46 94.28 94.20 63.02 50.26 36.80 Sundry Debtors 329.94 205.47 151.55 124.50 106.97 103.18 80.80 52.12 56.23 33.38 Cash & Bank 13.47 46.69 26.57 13.18 16.37 7.59 7.50 5.64 6.16 6.21 Other Current Assets 56.58 1.79 0.86 0.69 113.32 58.84 15.71 22.47 6.86 15.08 Short Term Loans & Adv. 52.83 26.71 26.21 27.81 112.48 57.74 15.33 21.38 6.10 12.45 Net Current Assets 228.42 175.90 134.35 96.92 33.53 46.17 29.66 15.07 15.84 7.87 Total Assets 1,092.54 860.19 521.40 392.06 492.71 310.23 235.22 174.67 152.20 127.29

Description Mar 24
Shareholder's Funds 532.56 Share Capital 10.03 Total Reserves 522.53 Non-Current Liabilities 187.93 Secured Loans 153.96 Unsecured Loans 0.00 Long Term Provisions 15.38 Current Liabilities 372.05 Trade Payables 166.27 Other Current Liabilities 56.48 Short Term Borrowings 142.02 Short Term Provisions 7.28 Total Liabilities 1,092.54 Net Block 158.89 Gross Block 246.23 Accumulated Depreciation 87.34 Non Current Assets 492.06 Capital Work in Progress 307.06 Non Current Investment 1.78 Long Term Loans & Adv. 23.12 Other Non Current Assets 1.21 Current Assets 600.48 Current Investments 0.00 Inventories 200.48 Sundry Debtors 329.94 Cash & Bank 13.48 Other Current Assets 56.58 Short Term Loans & Adv. 52.83 Net Current Assets 228.43 Total Assets 1,092.54

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -7.46 -26.59 106.24 87.25 47.10 5.21 -4.82 -4.13 -4.32 11.15 PBT 115.67 106.72 126.84 57.71 30.13 35.35 29.95 14.37 11.19 6.53 Adjustment 34.15 29.64 23.18 30.79 24.63 13.35 12.07 9.75 8.84 8.19 Changes in Working Capital -130.23 -135.25 -10.72 8.15 2.48 -33.52 -30.40 -23.70 -21.31 -1.60 Cash after chg. in Working capital 19.59 1.11 139.30 96.65 57.24 15.18 11.63 0.42 -1.28 13.12 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -27.04 -27.70 -33.06 -9.40 -10.14 -9.98 -16.44 -4.55 -2.65 -1.96 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 0.00 Cash From Investing Activity -102.40 -190.73 -94.59 -6.69 -42.53 -12.99 -8.84 -4.69 -0.51 -2.39 Net Fixed Assets -137.42 -195.35 -58.48 -16.45 -98.77 -13.77 -7.36 25.62 -0.50 -2.35 Net Investments -1.01 -0.77 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 36.03 5.39 -36.11 9.76 56.24 0.78 -1.48 -30.31 -0.01 -0.04 Cash from Financing Activity 82.38 234.31 -6.24 -78.62 -4.21 7.71 14.40 7.41 4.78 -5.09 Net Cash Inflow / Outflow -27.48 16.99 5.41 1.94 0.37 -0.08 0.75 -1.41 -0.05 3.67 Opening Cash & Equivalents 28.60 11.61 6.20 4.26 3.90 3.74 2.99 4.28 6.21 2.54 Closing Cash & Equivalent 1.13 28.60 11.61 6.20 4.26 3.66 3.74 2.87 6.16 6.21

Description Mar 24
Cash From Operating Activity -7.46 PBT 115.67 Adjustment 34.15 Changes in Working Capital -130.23 Cash after chg. in Working capital 19.59 Interest Paid 0.00 Tax Paid -27.04 Other Direct Exp. Paid 0.00 Extra & Other Items 0.00 Cash From Investing Activity -102.39 Net Fixed Assets Net Investments Others Cash from Financing Activity 82.38 Net Cash Inflow / Outflow -27.46 Opening Cash & Equivalents 28.60 Closing Cash & Equivalent 1.14

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 53.11 35.88 27.76 17.89 13.34 9.68 6.96 4.83 4.39 3.50 ROA 8.82% 11.54% 20.98% 10.00% 5.65% 8.04% 8.04% 5.52% 5.24% 3.49% ROE 19.57% 25.84% 43.31% 29.22% 22.17% 33.89% 36.03% 25.31% 23.99% 15.60% ROCE 17.37% 23.23% 47.29% 30.05% 21.01% 29.65% 34.10% 24.26% 24.24% 18.38% Fixed Asset Turnover 3.82 3.76 5.17 3.94 5.14 10.57 11.21 6.77 4.19 3.22 Receivable days 103.93 81.36 59.40 81.43 97.98 93.16 76.39 75.93 76.38 70.29 Inventory Days 74.53 68.14 45.18 76.30 101.05 95.44 90.36 79.39 74.21 71.80 Payable days 159.61 167.52 124.89 184.25 115.05 115.32 80.93 87.99 110.87 119.47 Cash Conversion Cycle 18.85 -18.02 -20.30 -26.52 83.98 73.27 85.82 67.32 39.73 22.62 Total Debt/Equity 0.60 0.90 0.23 0.32 0.90 1.30 1.47 1.52 1.26 1.21 Interest Cover 8.53 13.98 24.64 5.23 3.17 4.48 4.37 3.27 2.67 2.46

Description Mar 24
Book Value (Rs.) 53.11 ROA 7.88% ROE 16.17% ROCE 15.42% Fixed Asset Turnover 3.82 Receivable days 128.09 Inventory Days 77.83 Payable days 178.99 Cash Conversion Cycle 26.94 Total Debt/Equity 0.60 Interest Cover 8.53

Top Investors:

motilal oswal financial services ltd

jagdish n master

motilal oswal small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Gufic Biosciences - Quarterly Results
14th Feb 2025, 18:27 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback